Evidence map›Paper›PMID 42386546›Full record

ArticleEndocrine journal2026

Clinical characterization of Japanese children with Cushing's disease.

Mari Yamamoto, Yuri Mukoyama, Kentaro Kishi, Shun Moriguchi, Fumihiko Takizawa, Tetsushi Ogawa, Junko Ito, Susumu Yokoya, Hirokazu Fukuhara, Noriaki Fukuhara and 5 more

Abstract read
In one paragraph

Article in Endocrine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mari YamamotoDepartment of Pediatrics, Toranomon Hospital, Tokyo 105-8470, Japan.
Yuri MukoyamaDepartment of Pediatrics, Toranomon Hospital, Tokyo 105-8470, Japan.ORCID http://orcid.org/0009-0001-1530-7860
Kentaro KishiDepartment of Pediatrics, Toranomon Hospital, Tokyo 105-8470, Japan.
Shun MoriguchiDepartment of Pediatrics, Toranomon Hospital, Tokyo 105-8470, Japan.
Fumihiko TakizawaDepartment of Pediatrics, Toranomon Hospital, Tokyo 105-8470, Japan.
Tetsushi OgawaDepartment of Pediatrics, Toranomon Hospital, Tokyo 105-8470, Japan.
Junko ItoDepartment of Pediatrics, Toranomon Hospital, Tokyo 105-8470, Japan.
Susumu YokoyaDepartment of Pediatrics, Toranomon Hospital, Tokyo 105-8470, Japan.
Hirokazu FukuharaDepartment of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo 105-8470, Japan.
Noriaki FukuharaDepartment of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo 105-8470, Japan.
Masahiko TosakaDepartment of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo 105-8470, Japan.
Hiroshi NishiokaDepartment of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo 105-8470, Japan.
Shozo YamadaDepartment of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo 105-8470, Japan.
Masakazu MimakiDepartment of Pediatrics, Teikyo University School of Medicine, Tokyo 173-8605, Japan.
Tsuyoshi IsojimaDepartment of Pediatrics, Toranomon Hospital, Tokyo 105-8470, Japan.ORCID http://orcid.org/0000-0003-0011-0325

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cushing's disease (CD) is very rare in children. Nineteen children (≤18 years) with CD (median age at diagnosis: 13 [6-17] years; 12 females) were retrospectively analyzed using medical records (1994-2025) from Toranomon Hospital, Tokyo, Japan. Facial changes (88.9%), weight gain with decreased growth rate (88.9%), central obesity (88.9%) and hirsutism (94.4%) were frequently observed at diagnosis. Median time to diagnosis was 2.7 (0.25-5.8) years. Screening for endogenous hypercortisolism was assessed by 24-hour urinary free cortisol levels, serum cortisol levels at 23:00, and serum cortisol levels at 8:00 after a low-dose dexamethasone suppression test (DST), each with 100% sensitivity. Etiological diagnosis was evaluated by serum cortisol levels at 8:00 after a high-dose DST, plasma adrenocorticotropic hormone (ACTH) levels after a corticotropin-releasing hormone test, and plasma ACTH levels at 8:00, with sensitivities of 85.7%, 93.8%, and 83.3%, respectively. The actual tumor detection rate on magnetic resonance imaging (MRI) was 72.2%. Micro-pituitary neuroendocrine tumors were identified in 77.8% of patients. The total remission rate was 94.4% (median follow-up: 3.8 [0-10.4] years). The mean standard deviation scores (SDS) (SD) of height and body mass index (BMI) at onset and diagnosis were -0.45 (0.63) and -2.0 (1.1), and 0.61 (0.95) and 1.6 (0.75), respectively. Height and BMI SDS (SD) improved to -1.0 (0.80) and 0.091 (1.2) at the last visit (age: 11.4-17.5 years; follow-up: 1-8.6 years), respectively. This study revealed clinical characteristics of Japanese children with CD, including distinctive BMI SDS and a high tumor detection rate by MRI.

Indexed as

Pituitary ACTH HypersecretionAdolescentAdrenocorticotropic HormoneChildEast Asian PeopleFemaleHumansHydrocortisoneJapanMalePituitary NeoplasmsRetrospective StudiesAdrenocorticotropic HormoneHydrocortisoneCushing’s diseaseFacial changeGrowth failureJapanese children

Identifiers

PMID42386546
PMCPMC13755634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.